Cargando…
Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report
BACKGROUND: Since the beginning of the COVID-19 pandemic and development of new vaccines, the issue of post-vaccination exacerbation or manifestation of demyelinating central nervous system (CNS) disorders has gained increasing attention. CASE PRESENTATION: We present a case of a 68-year-old woman p...
Autores principales: | Lohmann, Lisa, Glaser, Felix, Möddel, Gabriel, Lünemann, Jan D., Wiendl, Heinz, Klotz, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114291/ https://www.ncbi.nlm.nih.gov/pubmed/35585528 http://dx.doi.org/10.1186/s12883-022-02698-y |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Cho, Eun Bin, et al.
Publicado: (2023) -
Elasomeran/tozinameran: Multiple sclerosis, exacerbation of multiple sclerosis and neuromyelitis optica: 7 case reports
Publicado: (2022) -
Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Chen, Hai, et al.
Publicado: (2016)